Pfizer Inc.
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Dr. Albert Bourla D.V.M., Ph.D.
- Full Time Employees
- 81,000
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Address
- 235 East 42nd Street New York NY United States of America 10017
- IPO Date
- Jun 1, 1972
- CIK
- 0000078003
- Website
- pfizer.com
- Similar Companies
- Business
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Company News
Tariffs on generic drugs will cause companies to stop making them: Former FDA Commissioner Gottlieb
The Tariff Game Just Changed: 7 Blue-Chip Bargains To Buy Now
Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?
Trump Says Pharmaceutical Tariffs Coming in Near Future
Trump says US pharma tariffs coming in not-too-distant future
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
Biotech Stock A Big Winner After Pfizer Halts Weight-Loss Drug
Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury'
Pfizer discontinues development of weight loss pill
Pfizer ends development of weight-loss pill danuglipron
Pfizer scraps daily weight loss pill after liver injury in one patient
Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giant
Pfizer Halts Development of New Weight-Loss Drug
Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
As the market dips, I'm eyeing dividend plays like KO and PM – what stocks are on your buy list right now?
3 Dividend Stocks for April 2025
Buy 9 'Safer' Dividend Dogs Of 23 April Barron's Better Bets Than T-Bills
1 Deeply Undervalued Stock to Buy in the Market Correction
Pfizer (PFE) Advances But Underperforms Market: Key Facts
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages